Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

NCT00335595 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: XELOXA
DRUG: XELOXA-A

Sponsor

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Collaborators

[object Object]
[object Object]